These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 33173039)

  • 21. α-Synuclein and mitochondria: partners in crime?
    Nakamura K
    Neurotherapeutics; 2013 Jul; 10(3):391-9. PubMed ID: 23512373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons.
    Ganjam GK; Bolte K; Matschke LA; Neitemeier S; Dolga AM; Höllerhage M; Höglinger GU; Adamczyk A; Decher N; Oertel WH; Culmsee C
    Cell Death Dis; 2019 Nov; 10(11):865. PubMed ID: 31727879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson's Disease.
    Portz P; Lee MK
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
    Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
    [No Abstract]   [Full Text] [Related]  

  • 26. Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management.
    Phillipson OT
    Ageing Res Rev; 2017 Nov; 40():149-167. PubMed ID: 28986235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.
    Chen L; Xie Z; Turkson S; Zhuang X
    J Neurosci; 2015 Jan; 35(3):890-905. PubMed ID: 25609609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
    Burbulla LF; Song P; Mazzulli JR; Zampese E; Wong YC; Jeon S; Santos DP; Blanz J; Obermaier CD; Strojny C; Savas JN; Kiskinis E; Zhuang X; Krüger R; Surmeier DJ; Krainc D
    Science; 2017 Sep; 357(6357):1255-1261. PubMed ID: 28882997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization.
    Lurette O; Martín-Jiménez R; Khan M; Sheta R; Jean S; Schofield M; Teixeira M; Rodriguez-Aller R; Perron I; Oueslati A; Hebert-Chatelain E
    Cell Death Dis; 2023 Nov; 14(11):729. PubMed ID: 37949858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum.
    Melo TQ; Copray SJCVM; Ferrari MFR
    Neurochem Res; 2018 Dec; 43(12):2212-2223. PubMed ID: 30370500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine‑iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.
    Buoso C; Seifert M; Lang M; Griffith CM; Talavera Andújar B; Castelo Rueda MP; Fischer C; Doerrier C; Talasz H; Zanon A; Pramstaller PP; Schymanski EL; Pichler I; Weiss G
    Neurobiol Dis; 2024 Jun; 196():106506. PubMed ID: 38648865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson's Disease.
    Zhu XX; Zhong YZ; Ge YW; Lu KH; Lu SS
    Sci Rep; 2018 Aug; 8(1):12420. PubMed ID: 30127453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein.
    Vicario M; Cieri D; Vallese F; Catoni C; Barazzuol L; Berto P; Grinzato A; Barbieri L; Brini M; Calì T
    Cell Death Dis; 2019 Nov; 10(11):857. PubMed ID: 31719530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca
    Paillusson S; Gomez-Suaga P; Stoica R; Little D; Gissen P; Devine MJ; Noble W; Hanger DP; Miller CCJ
    Acta Neuropathol; 2017 Jul; 134(1):129-149. PubMed ID: 28337542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson's disease.
    Milanese C; Cerri S; Ulusoy A; Gornati SV; Plat A; Gabriels S; Blandini F; Di Monte DA; Hoeijmakers JH; Mastroberardino PG
    Cell Death Dis; 2018 Jul; 9(8):818. PubMed ID: 30050065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease.
    Chen Z; Rasheed M; Deng Y
    Brain Pathol; 2022 May; 32(3):e13012. PubMed ID: 34414627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new role for α-synuclein in Parkinson's disease: Alteration of ER-mitochondrial communication.
    Guardia-Laguarta C; Area-Gomez E; Schon EA; Przedborski S
    Mov Disord; 2015 Jul; 30(8):1026-33. PubMed ID: 25952565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggregated α-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons.
    Reeve AK; Ludtmann MH; Angelova PR; Simcox EM; Horrocks MH; Klenerman D; Gandhi S; Turnbull DM; Abramov AY
    Cell Death Dis; 2015 Jul; 6(7):e1820. PubMed ID: 26181201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson's Disease: Roads to Biomarker Discovery.
    Picca A; Guerra F; Calvani R; Romano R; Coelho-Júnior HJ; Bucci C; Marzetti E
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease.
    Haque ME; Akther M; Azam S; Kim IS; Lin Y; Lee YH; Choi DK
    Br J Pharmacol; 2022 Jan; 179(1):23-45. PubMed ID: 34528272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.